MA
SCMP

MUFG Americas’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

MUFG Americas’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-240
Closed -$5K – 1279
2015
Q3 		$5K Buy
+240
New +$5.5K ﹤0.01% 974

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

MUFG Americas's SCMP Position: Q4 2015 in Review

MUFG Americas sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 240 shares — an estimated $5K sold.

MUFG Americas first reported a position in SCMP in Q3 2015 and held it in 1 quarter. The position peaked at $5K in Q3 2015. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

  • MUFG Americas reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • MUFG Americas sold 240 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $5K.
  • MUFG Americas first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • MUFG Americas's Sucampo Pharmaceuticals, Inc. position peaked at $5K in Q3 2015.
  • 149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on MUFG Americas's 13F filing for Q4 2015, filed 10 Feb 2016.